
Publicis Groupe has acquired an Israeli startup called AdgeAI. The startup was built without taking any outside funding and ran on its own earnings.
The deal is estimated to be worth around $100 million. However, the companies did not officially reveal the exact amount when they announced the acquisition earlier this month.
Publicis Groupe is buying AdgeAI’s technology to add it to its own systems. This will help Publicis offer better tools for creating ads and improving their performance.
At the same time, AdgeAI will keep running as a company and continue growing its products in the fast-growing brand marketing space.
AdgeAI has built a platform that uses smart AI agents to help marketing and growth teams in big companies.
Unlike basic AI tools that only help create content, this system can handle the full marketing process. It studies campaign performance, makes changes on its own to improve results, and aims to increase return on investment. The AI agents can also connect with tools like Salesforce and Google Ads, so they can directly manage and optimize campaigns.
“This is a defining moment not just for Adge, but for how the industry thinks about creative intelligence. By bringing our technology into Publicis’ existing engine, we’re giving brands something they’ve never had before; the ability to move at the speed of the algorithm without losing the spark of great creative,” said Eyal Ben Shalom, Co-Founder and CEO of AdgeAI.
Arthur Sadoun, Chairman & CEO Publicis Groupe, said: “With the acquisition of AdgeAI, we are bridging the gap between instinct and proven performance, transforming creative performance measurement from a retrospective report into a forward-looking capability that anticipates and delivers real business outcomes.”
AdgeAI was founded just a few days before the October 7 attacks by brothers Eyal Ben Shalom and Asaf Ben Shalom.
The company works with some of the world’s biggest brands and platforms. Its AI-powered tool helps improve ads and videos by studying user engagement and conversion data, finding what works best, and giving useful insights to create better content and increase returns on marketing campaigns.
Read More- Biotechnology company Scala Biodesign raises $16 million Series A round




